mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.2 |
0.0005 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0006 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |